This research introduces High-Resolution Imaging Mass Cytometry (HR-IMC), a novel method that significantly enhances the spatial detail of traditional multiplexed tissue imaging. By employing an oversampling technique and computational deconvolution, the researchers improved resolution from 1 µm to below 350 nm, matching the performance of light microscopy. This advancement allows scientists to visualize subcellular structures like mitochondrial networks and nuclear foci that were previously invisible using standard mass cytometry. Validation across diverse tissue types, including ovarian cancer cells, demonstrates that HR-IMC provides superior cell segmentation and more accurate biomarker mapping. Ultimately, the technology offers a powerful tool for studying complex biological features and disease characteristics at a nearly microscopic level.

References:

• Bollhagen A, Whipman J, Coelho R, et al. High-resolution imaging mass cytometry to map subcellular structures[J]. Nature Methods, 2025: 1-8.

This research introduces Spotiphy, a new computational method designed to analyze spatially resolved transcriptomics data with high precision. By integrating single-cell and spatial datasets, the authors examine the complex tissue microenvironment in conditions like Alzheimer’s disease and breast cancer. The study successfully identifies specific cell populations, such as disease-associated microglia, and maps their physical proximity to amyloid plaques. Additionally, the researchers utilize these tools to uncover how cell-cell communication and mobility change across different spatial layers within malignant tumors. Through advanced probabilistic modeling, the work provides a clearer understanding of how the location of a cell influences its biological function and role in disease progression.

References:

• Yang J, Zheng Z, Jiao Y, et al. Spotiphy enables single-cell spatial whole transcriptomics across an entire section[J]. Nature Methods, 2025: 1-13.

This article introduces LEVA, a versatile method for precisely micropatterning extracellular vesicles (EVPs) onto various surfaces using light-induced adsorption. Unlike traditional methods that rely on specific antibodies, this technique uses UV-light exposure to create high-resolution templates, allowing researchers to control the exact location and density of particles. By successfully arranging different types of vesicles—including those from bacteria and glioblastoma cells—the authors demonstrate how these patterns can guide cell migration and trigger immune responses like neutrophil swarming. The study highlights the platform's ability to mimic complex biological environments, providing a scalable tool for investigating how surface-bound vesicles influence disease and healing. Ultimately, the authors present this approach as a way to enhance rigor and reproducibility in the growing field of nanoparticle characterization and immunoengineering.

References:

• Hisey C L, Rima X Y, Doon-Ralls J, et al. Light-induced extracellular vesicle and particle adsorption[J]. Nature Methods, 2025: 1-13.

The paper introduces Jaxley, a novel differentiable simulation framework designed to bridge the gap between detailed biophysical neuron models and modern machine learning techniques. By utilizing JAX-based automatic differentiation and GPU acceleration, Jaxley allows researchers to optimize complex neural parameters—such as ion channel conductances and synaptic weights—using gradient descent rather than slower, gradient-free methods. The authors demonstrate that this tool can efficiently fit models to physiological recordings, train recurrent networks for memory tasks, and even scale to large-scale networks capable of image recognition. Ultimately, Jaxley provides a powerful, Python-based ecosystem for investigating the mechanistic foundations of neural computation across various biological scales.

References:

• Deistler M, Kadhim K L, Pals M, et al. Jaxley: differentiable simulation enables large-scale training of detailed biophysical models of neural dynamics[J]. Nature Methods, 2025: 1-9.

The article introduces Novae, a graph-based foundation model designed to analyze spatial transcriptomics data across diverse tissues and technologies. Traditional methods often struggle with batch effects and predefined gene panels, but Novae utilizes self-supervised learning and optimal transport to identify consistent spatial domains without these limitations. By employing a graph attention encoder and learnable prototypes, the model can process millions of cells efficiently while maintaining high spatial resolution. Research highlights its ability to integrate with H&E staining and protein assays to reveal complex immune interactions in cancers and architectural shifts in diseased tissues. Ultimately, Novae serves as a scalable, zero-shot tool that enables researchers to discover new biological biomarkers by harmonizing data from various experimental platforms.

References:

• Blampey Q, Benkirane H, Bercovici N, et al. Novae: a graph-based foundation model for spatial transcriptomics data[J]. Nature Methods, 2025, 22(12): 2539-2550.

Researchers have developed Bin Chicken, an automated algorithm designed to recover microbial genomes from low-abundance lineages that are typically missed by standard metagenomic methods. By using marker gene sequences from raw data to intelligently group samples for coassembly, the tool identifies unique genetic diversity without the need for additional sequencing costs. Applying this method to thousands of public datasets, the authors successfully reconstructed over 77,000 microbial genomes, including thousands of previously unknown species and representatives of six entirely new phyla. The study reveals that these rare biosphere organisms often possess unique anaerobic metabolisms and represent a significant expansion of the known tree of life. Ultimately, Bin Chicken demonstrates that targeted coassembly is an exceptionally efficient strategy for uncovering the vast, hidden genomic potential of the global microbiome.

References:

• Aroney S T N, Newell R J P, Tyson G W, et al. Bin Chicken: targeted metagenomic coassembly for the efficient recovery of novel genomes[J]. Nature Methods, 2025: 1-9.

The paper introduces STAIR, a novel computational framework designed to reconstruct three-dimensional (3D) biological atlases from two-dimensional spatial transcriptomics (ST) data. Traditional methods often struggle with batch effects and unknown physical distances between tissue slices, but STAIR addresses these issues using a heterogeneous graph attention network that adaptively integrates molecular and spatial features. This end-to-end tool is uniquely capable of unsupervised z-axis reconstruction, allowing researchers to determine the relative positioning of slices without prior anatomical measurements. Beyond 3D construction, STAIR facilitates 2D alignment and the integration of new tissue sections into existing reference frameworks across different samples and sequencing platforms. Benchmarking across diverse datasets, including the mouse brain and human breast cancer tissues, demonstrates its superior accuracy in identifying spatial domains and capturing complex biological heterogeneity. Ultimately, STAIR provides a robust solution for visualizing organ-level architecture and understanding the spatial molecular drivers of tissue organization.

References:

• Yu Y, Xie Z. Spatial transcriptomic alignment, integration, and 3D reconstruction by STAIR[J]. Genome Biology, 2025, 26(1): 427.

This research introduces MetroSCREEN, a computational framework designed to map the metabolic landscape of individual cells by integrating gene expression with regulatory mechanisms. By analyzing single-cell transcriptomic data, the tool calculates MetaModule scores to identify specific metabolic subtypes and uses causal inference to pinpoint the internal and external factors driving these states. The authors demonstrate how metabolic reprogramming—such as the shift between glycolysis and oxidative phosphorylation—correlates with the specialized functions of fibroblasts and macrophages within the tumor microenvironment. Their findings reveal that these metabolic profiles are closely linked to immunosuppression and patient survival outcomes, suggesting that metabolic signatures can predict how well a person might respond to immunotherapy. Ultimately, this work provides a comprehensive platform, MetroTIME, to help scientists discover new therapeutic targets by understanding the complex chemistry of cancer-associated cells.

References:

• Tang K, Han Y, Sun D, et al. Reference-guided computational framework identifies microenvironment metabolic subtypes and targets using pan-cancer single-cell datasets[J]. Genome Medicine, 2025, 17(1): 150.

This roadmap article explores how brain organoids serve as a sophisticated bridge between traditional cell cultures and living animal models. By utilizing pluripotent stem cells, researchers can grow three-dimensional structures that replicate the early stages of human neocortex development and evolutionary history. These models are particularly effective for investigating neurodevelopmental disorders, such as microcephaly and autism, as well as the impact of infectious diseases like Zika and SARS-CoV-2. The text also highlights the integration of bioengineering and CRISPR technology to enhance the physiological accuracy of these tissues. Finally, the authors address necessary ethical considerations regarding donor consent and the potential for consciousness in advanced models.

References:

• Birtele M, Lancaster M, Quadrato G. Modelling human brain development and disease with organoids[J]. Nature Reviews Molecular Cell Biology, 2025, 26(5): 389-412.

This article explores how triple-negative breast cancer (TNBC) responds to a combination of pembrolizumab and radiation therapy through advanced single-cell and spatial profiling. By analyzing patient biopsies over time, the authors identified 12 distinct spatial districts and three specific response trajectories among patients. While some individuals showed an immediate immune response, a second group only achieved a significant clinical benefit after the addition of radiation. Conversely, non-responders remained immunologically inactive throughout the treatment, often characterized by low MHC expression. The study suggests that radiation can bridge the gap for certain patients by inducing antigen-presenting macrophages and expanding effector T cells. Ultimately, these findings provide a framework for using spatial biomarkers to personalize immunotherapy and improve survival in difficult-to-treat cancers.

References:

• Shiao SL, Knott SRV. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024 Jan 8;42(1):70-84.e8. doi: 10.1016/j.ccell.2023.12.012. PMID: 38194915.